poland
sever
thousand
sever
million
case
influenza
suspect
influenza
case
regist
depend
epidem
season
varieti
method
avail
detect
influenza
virus
respons
respiratori
infect
start
isol
viru
chick
embryo
cell
line
mdck
vero
etc
finish
varieti
modif
classic
pcr
molecular
biolog
pcr
multiplex
realtim
effect
way
combat
influenza
vaccin
regular
vaccin
one
step
may
taken
protect
individu
especi
highrisk
group
potenti
seriou
complic
influenza
mani
countri
includ
poland
despit
recommend
rate
vaccin
influenza
still
low
age
group
epidem
season
level
distribut
season
influenza
vaccin
popul
statement
made
american
research
kelvin
sullivan
last
centuri
influenza
last
uncontrol
plagu
mankind
continu
valid
begin
twentyfirst
centuri
influenza
diseas
pathognomon
characterist
therefor
diagnosi
infect
base
upon
clinic
symptom
possibl
epidem
known
influenzalik
symptom
may
occur
infect
virus
includ
parainfluenza
viru
adenoviru
rhinoviru
coronaviru
respiratori
syncyti
viru
coxacki
viru
caus
diseas
preval
time
influenza
viru
brydak
import
bear
mind
materi
sampl
upper
respiratori
tract
examin
varieti
way
therefor
laboratori
confirm
infect
influenza
viru
import
control
influenza
play
import
role
evalu
effect
vaccin
antiinfluenza
medic
landri
basic
virolog
laboratori
diagnosi
influenza
involv
confirm
presenc
viral
antigen
specimen
patient
serolog
confirm
influenza
viru
infect
base
increas
level
antibodi
detect
patient
serum
brydak
landri
influenza
diseas
continu
evolut
viru
essenti
occurr
annual
epidem
human
popul
occasion
pandem
complic
influenza
occur
includ
respiratori
system
circulatori
system
caus
graft
reject
otiti
media
myocard
pericard
toxic
shock
syndrom
myositi
myoglobinuria
may
lead
renal
failur
glomerulonephr
exacerb
chronic
glomerulonephr
worsen
chronic
kidney
failur
neurolog
complic
central
nervou
system
cerebrovascular
diseas
enceph
complic
women
pregnant
etc
brydak
although
infect
influenza
viru
caus
multiorgan
complic
often
death
age
group
rang
million
individu
worldwid
proport
popul
vaccin
poland
place
countri
bottom
list
europ
brydak
beg
question
view
prevent
vaccin
chang
death
love
one
aim
articl
review
current
molecular
method
influenza
diagnosi
prevent
latter
name
vaccin
sinc
isol
influenza
viru
grown
chick
embryo
becom
gold
standard
diagnosi
influenza
must
perform
despit
labori
often
take
dozen
day
patient
specimen
often
requir
sever
passag
obtain
viral
hemagglutinin
titer
use
varieti
test
krauss
et
al
isol
influenza
viru
respons
current
infect
identif
determin
antigen
similar
strain
circul
given
season
necessari
develop
vaccin
ie
select
candid
strain
vaccin
step
also
import
epidemiolog
standpoint
georg
mani
year
isol
influenza
viru
perform
chick
embryo
tissu
cultur
known
time
propag
tissu
cultur
possibl
case
although
method
confirm
presenc
influenza
viru
specimen
patient
concern
therefor
first
instanc
replic
viru
occur
chick
embryo
worth
note
influenza
vaccin
current
also
produc
tissu
cultur
mdck
vero
dwyer
et
al
earli
correct
complet
diagnosi
influenza
particular
import
time
term
treatment
also
detect
new
unidentifi
pathogen
case
mani
time
past
brydak
ganzenmuel
et
al
isol
influenza
viru
patient
give
valuabl
inform
type
subtyp
viru
circul
territori
given
popul
import
context
global
influenza
surveil
respons
system
brydak
also
pertin
cost
incur
treatment
patient
hospit
case
misdiagnosi
nitschosuch
et
al
tradit
diagnost
method
detect
influenza
viru
specimen
patient
also
includ
analysi
base
detect
viral
antigen
immunofluoresc
immunoenzymat
immunochromatograph
assay
brydak
serolog
method
much
faster
less
costli
viral
cultur
method
may
lower
sensit
specif
compar
cultur
method
describ
immunofluoresc
test
enabl
identif
antigen
specif
type
influenza
viru
clinic
sampl
use
frequent
kapelusznik
et
al
berg
et
al
method
util
specif
antibodi
label
fluoresc
dye
fluorescein
bind
particular
antigen
influenza
viru
type
b
posit
result
obtain
antigen
antibodi
complex
emit
green
light
visibl
contrast
background
stain
human
epitheli
cell
read
taken
fluoresc
microscop
nutter
et
al
direct
fluorescentantibodi
test
high
specif
lower
sensit
bakerman
et
al
immunoenzymat
test
ie
also
use
diagnost
laboratori
rapid
detect
influenza
viru
antigen
sever
evalu
compar
immunoassay
classic
method
viru
cultur
shown
sensit
ie
highli
variabl
rang
type
influenza
viru
jen
et
al
rapicetta
et
al
decemb
march
period
greater
incid
respiratori
infect
increas
ie
influenza
viru
sensit
also
evid
petric
et
al
relationship
account
decreas
human
immun
typic
autumnspr
season
may
contribut
rapid
replic
influenza
viru
rel
long
persist
viral
particl
bodi
brydak
kumar
henrickson
ie
test
enabl
simultan
detect
differenti
influenza
b
basi
test
perform
nasopharyng
aspir
patient
specif
test
influenza
b
averag
sensit
influenza
type
influenza
b
brydak
brydak
rapid
test
detect
influenza
viru
antigen
base
method
immunochromatographi
ic
also
avail
test
provid
confirm
presenc
influenza
virus
within
min
nitschosuch
et
al
sinc
simpl
use
find
practic
applic
especi
set
primari
care
famili
medicin
nitschosuch
et
al
evalu
diagnost
valu
rapid
immunochromatograph
test
detect
antigen
influenza
viru
type
b
specimen
respiratori
tract
reveal
sensit
specif
detect
two
type
viru
respect
kok
et
al
nitschosuch
et
al
stress
diagnost
sensit
differ
type
strip
cassett
immunochromatograph
test
immunoassay
much
less
reliabl
revers
transcriptas
polymeras
chain
reaction
rtpcr
howev
easier
perform
requir
use
equip
highli
qualifi
personnel
petrozzino
et
al
takahashi
et
al
furthermor
estim
cost
singl
ic
test
time
lower
cost
incur
case
molecular
method
test
gener
design
use
acut
phase
infect
virion
number
less
pfu
plaqu
form
unit
sampl
taken
late
recoveri
period
store
improperli
may
contain
antigen
concentr
detect
limit
brydak
jacobu
raja
nitschosuch
et
al
doubt
reliabl
result
especi
inconsist
clinic
sign
resolv
basi
refer
test
appli
molecular
biolog
techniqu
bigg
et
al
case
influenza
viru
rtpcr
method
use
specif
primer
correspond
thermal
profil
amplif
reaction
georg
virolog
diagnosi
also
includ
serolog
test
involv
detect
specif
antibodi
defin
type
influenza
viru
although
limit
use
especi
rapid
diagnosi
respiratori
infect
brydak
employ
method
particular
attent
given
time
elaps
sinc
onset
symptom
type
test
involv
measur
level
specif
antiinfluenza
antibodi
often
antihemagglutinin
brydak
chang
level
antibodi
serum
sampl
period
acut
ill
recoveri
week
may
confirm
refut
presenc
infect
influenza
viru
hemagglutin
inhibit
test
hi
neuraminidas
inhibit
test
ni
perform
frequent
research
studi
evalu
humor
immun
respons
vaccin
influenza
viru
brydak
nucleic
acid
amplif
method
play
increasingli
import
role
diagnosi
influenza
viru
character
much
higher
sensit
specif
classic
techniqu
molecular
detect
viral
rna
also
provid
earli
detect
influenza
viru
infect
alreadi
onset
symptom
virion
number
reach
level
requir
method
brydak
landri
polymeras
chain
reaction
pcr
highli
specif
amplif
select
nucleic
acid
fragment
specif
type
influenza
viru
determin
sequenc
specif
primer
use
reaction
poon
et
al
visual
result
pcr
amplif
product
made
possibl
separ
agaros
gel
less
frequent
polyacrylamid
gel
use
fluoresc
dye
eg
ethidium
bromid
intercal
doublestrand
dna
brydak
influenza
viru
belong
orthomyxovirida
famili
store
genet
inform
rna
sequenc
identif
influenza
viru
requir
recod
dna
sequenc
deriv
complementari
dnacdna
amplif
characterist
fragment
genom
modif
pcr
ad
revers
transcript
step
known
revers
transcriptasepcr
rtpcr
reaction
may
take
two
form
one
stage
process
onestep
rtpcr
revers
transcript
pcr
reaction
perform
one
test
tube
altern
two
stage
process
twostep
rtpcr
transcript
viral
rna
cdna
first
stage
amplif
certain
sequenc
second
stage
brydak
brydak
numer
scientif
report
indic
twostep
process
character
better
sensit
poon
et
al
wang
taubenberg
order
detect
presenc
factor
test
sampl
inhibit
pcr
reaction
intern
control
perform
use
primer
complementari
sequenc
refer
gene
alway
express
human
epitheli
cell
gene
includ
rnaas
ornithin
decarboxylas
brydak
view
larg
variabl
influenza
viru
detect
clinic
specimen
necessit
use
primer
complementari
highli
conserv
gene
sequenc
region
minim
variat
within
gene
conserv
influenza
viru
gene
encod
protein
nucleoprotein
usual
use
design
primersprob
order
differenti
strain
influenza
viru
type
primersprob
hybrid
conserv
region
gene
hemagglutinin
neuraminidas
brydak
convent
pcr
method
increasingli
replac
realtim
pcr
use
fluoresc
techniqu
enabl
monitor
amplif
product
cycl
pcr
reaction
brydak
prefer
simplif
autom
technolog
significantli
less
timeconsum
process
main
advantag
method
quantit
natur
contrast
classic
pcr
method
provid
qualit
result
presentabs
label
probe
bind
replic
viral
rna
provid
measur
number
particl
allow
determin
initi
level
viremia
monitor
effect
therapi
patient
influenza
brydak
main
disadvantag
diagnost
method
cost
scientif
report
indic
test
durat
much
shorter
h
rapid
confirm
viral
etiolog
infect
may
explain
use
expens
test
routin
diagnost
georg
wang
taubenberg
furthermor
refrain
administ
antibiot
rapid
inclus
appropri
treatment
factor
support
use
method
test
develop
base
method
multiplex
realtim
pcr
make
possibl
simultan
identif
influenza
viru
type
b
parainfluenza
hmpv
rsv
rhinoviru
enteroviru
adenoviru
coronaviru
atyp
mycoplasma
pneumonia
chlamydia
pneumonia
microorgan
nasopharyng
secret
author
report
matter
estim
cost
analysi
singl
clinic
specimen
test
significantli
lower
compar
standard
method
detect
singl
pathogen
amount
euro
brydak
sinc
known
influenza
vaccin
cheapest
effect
way
fight
infect
brydak
current
medic
practition
avail
market
mani
tabl
influenza
vaccin
regist
poland
brydak
type
inactiv
influenza
vaccin
differ
variant
contain
differ
adjuv
without
brydak
brydak
anoth
type
vaccin
deriv
socal
cold
adapt
influenza
viru
adapt
reduc
replic
temperatur
brydak
technolog
allow
develop
vaccin
egg
mdck
vero
tissu
cultur
method
produc
clean
safe
effect
inactiv
vaccin
appli
mani
year
current
use
latest
molecular
biolog
techniqu
mean
strain
influenza
viru
use
vaccin
influenza
appear
almost
compat
appear
follow
epidem
season
influenza
vaccin
prepar
egg
tissu
cultur
regist
poland
list
tabl
brydak
tabl
show
inactiv
influenza
vaccin
regist
poland
brydak
advisori
committe
immun
practic
acip
first
recommend
season
influenza
vaccin
person
age
month
vaccin
offer
throughout
influenza
epidem
season
recommend
acip
b
intern
scientif
societi
essenti
vaccin
greatest
possibl
percentag
popul
world
brydak
brydak
vaccin
influenza
includ
individu
clinic
indic
ie
highrisk
group
particularli
vulner
occurr
complic
well
healthi
individu
posit
transmit
influenza
person
high
risk
identifi
sourc
infect
peopl
accord
data
nation
institut
public
health
nation
institut
hygien
niphnih
proport
popul
vaccin
influenza
per
age
categori
year
remain
low
level
level
vaccin
children
month
year
age
shame
low
vaccin
level
somewhat
better
children
age
age
percentag
vaccin
popul
year
accord
niphnih
data
satisfactori
level
even
though
marshal
offic
lead
provinc
offer
free
influenza
vaccin
individu
age
year
epidem
season
percentag
vaccin
popul
age
rang
low
fluctuat
round
brydak
embarrassingli
contrast
vaccin
remain
low
level
health
worker
season
popul
poland
vaccin
despit
tabl
recommend
intern
scientif
societi
influenza
vaccin
brydak
fact
ternari
composit
includ
pandem
viru
brydak
possibl
strategi
increas
influenza
vaccin
coverag
includ
implement
nation
influenza
immun
programm
person
invit
letter
telephon
call
patient
effect
commun
perform
method
use
identifi
contact
elig
patient
educ
activ
dedic
patient
medic
profession
provid
patient
free
charg
vaccin
reimburs
brydak
term
percentag
popul
vaccin
influenza
poland
hold
penultim
place
europ
brydak
reason
low
preval
influenza
vaccin
includ
lack
suffici
accept
form
prevent
doctor
lack
awar
legal
oblig
doctor
recommend
vaccin
insuffici
knowledg
cost
influenza
complic
individu
case
countri
whole
insuffici
knowledg
type
vaccin
expect
vaccin
protect
upper
respiratori
tract
infect
confus
influenza
common
cold
exampl
call
stomach
flu
respiratori
infect
frequent
advers
event
vaccin
confus
complic
influenza
need
repeat
vaccin
everi
epidemiolog
season
brydak
brydak
also
mani
myth
within
societi
must
shown
fals
idea
inocul
caus
infect
poland
influenza
vaccin
inactiv
contain
fragment
kill
viru
split
subunit
unabl
multipli
bodi
caus
diseas
seriou
problem
includ
anaphylact
reaction
inactiv
influenza
vaccin
rare
minor
side
effect
could
occur
local
side
effect
sore
red
swell
shot
given
fever
low
grade
ach
headach
fatigu
brydak
one
awar
apart
recommend
acip
b
also
scientif
societi
list
tabl
also
recommend
vaccin
influenza
increasingli
issu
vaccin
consid
health
aspect
also
term
econom
impact
often
taken
account
studi
conduct
influenza
virus
research
depart
nation
influenza
center
niphnih
collabor
clinician
includ
vulner
group
clearli
indic
possibl
produc
humor
immun
respons
patient
consequ
protect
harm
complic
influenza
shown
tabl
studi
aim
convinc
high
risk
also
medic
personnel
necess
influenza
vaccin
especi
group
tabl
studi
conduct
research
depart
influenza
virus
nation
influenza
center
niphnih
poland
collabor
clinician
group
risk
evalu
humor
immun
respons
influenza
vaccin
brydak
brydak
children
age
month
year
year
year
brydak
children
acut
lymphoblast
leukemia
vaccin
differ
time
treatment
brydak
et
al
brydak
et
al
b
children
sever
hemophilia
brydak
et
al
b
children
bronchopulmonari
dysplasia
brydak
et
al
children
glomerulonephr
brydak
et
al
children
chronic
renal
failur
subject
continu
ambulatori
periton
dialysi
hemodialysi
chronic
renal
failur
vaccin
twice
brydak
et
al
children
infect
hiv
children
vaccin
splenectomi
age
group
year
year
year
brydak
et
al
b
children
aplast
anemia
children
bronchial
asthma
children
inflammatori
bowel
diseas
brydak
adult
adult
age
year
brydak
et
al
brydak
et
al
billet
student
militari
medic
academi
brydak
et
al
patient
acut
lymphoblast
leukemia
brydak
calbecka
patient
chronic
renal
failur
koziolmontewka
et
al
patient
renal
allograft
recipi
wyzgal
et
al
patient
infect
hiv
variou
level
symptom
aid
asymptomat
patient
breast
cancer
brydak
et
al
patient
asthma
jahnzrozyk
et
al
patient
group
young
elderli
brydak
et
al
patient
acut
cardiovascular
event
ciszewski
et
al
patient
malign
lymphoma
brydak
et
al
patient
lupu
wiesikszewczyk
et
al
patient
primari
system
vascular
inflamm
wegen
granulomatosi
zycinska
et
al
regular
vaccin
part
sound
medic
practic
health
care
famili
therefor
recommend
undergo
season
vaccin
protect
measur
brydak
brydak
basi
extens
literatur
clear
vaccin
influenza
prevent
mani
complic
mortal
also
bring
measur
econom
benefit
whole
state
budget
noteworthi
complic
influenza
infect
may
occur
previous
healthi
individu
accord
articl
act
decemb
prevent
fight
infect
infecti
diseas
human
journal
law
item
enter
forc
januari
physician
must
inform
patient
provis
act
concern
protect
vaccin
list
relev
ordin
failur
fulfil
requir
may
result
crimin
prosecut
judgment
accord
provis
act
date
august
code
petti
offens
act
journal
law
item
item
offer
organ
vaccin
influenza
especi
highrisk
group
regard
ethic
oblig
effect
detect
respiratori
virus
includ
influenza
viru
possibl
thank
advanc
made
recent
year
diagnosi
virolog
infect
select
appropri
test
depend
type
viru
detect
presum
amount
antigen
popul
patient
technic
capabl
experi
analyst
import
clinic
aspect
select
test
provid
inform
less
h
diagnosi
influenza
method
common
use
includ
immunofluoresc
test
due
mainli
short
durat
rel
simpl
methodolog
molecular
test
use
nucleic
acid
amplif
high
sensit
specif
also
concurr
detect
pathogen
clinic
specimen
order
develop
appropri
vaccin
epidem
season
nation
influenza
center
current
oper
throughout
world
send
one
thousand
isol
refer
center
influenza
applic
molecular
diagnost
provid
type
subtyp
influenza
viru
determin
appropri
composit
vaccin
given
epidem
season
